Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09WGH
|
|||
| Former ID |
DIB002375
|
|||
| Drug Name |
Ropidoxuridine
|
|||
| Synonyms |
IPdR; IPdR (LADD), Hana; IPdR, (LADD) SuperGen; 5-iodo-pyrimidinone-2'-deoxyribose; 5-iodo-pyrimidinone-2-deoxyribose (LADD), SuperGen
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Gastrointestinal cancer [ICD-11: 2C11] | Phase 1 | [1] | |
| Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Phase 1 | [2] | ||
| Company |
State University of New York
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C9H11IN2O4
|
|||
| Canonical SMILES |
C1C(C(OC1N2C=C(C=NC2=O)I)CO)O
|
|||
| InChI |
1S/C9H11IN2O4/c10-5-2-11-9(15)12(3-5)8-1-6(14)7(4-13)16-8/h2-3,6-8,13-14H,1,4H2/t6-,7+,8+/m0/s1
|
|||
| InChIKey |
XIJXHOVKJAXCGJ-XLPZGREQSA-N
|
|||
| CAS Number |
CAS 93265-81-7
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | ClinicalTrials.gov (NCT02381561) Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.